Microbiology Testing for CSF-Contacting and Neurosurgical Devices
Shunts, drains, intrathecal catheters, and neurosurgical implants contact cerebrospinal fluid — the most endotoxin-sensitive route in the medical device industry. CSF-contact endotoxin limits are 10x stricter than blood-contact. Boulder BioLabs supports CSF-contacting device manufacturers through full validation and routine release.
Tests This Industry Requires
- Sterility Testing
- LAL / Endotoxin Testing
- EO Residuals Testing
- CD Sterilization Residuals
- Bioburden Testing
- Method Suitability (B/F)
What Makes CSF & Neurosurgical Testing Different
FDA's 2015 guidance sets the CSF-contacting endotoxin limit at 2.15 EU/device — roughly an order of magnitude stricter than the 20 EU/device blood-contact limit. That tighter limit drives method selection (typically kinetic chromogenic LAL) and increases the importance of the inhibition/enhancement study.
The CSF Endotoxin Limit
FDA's 2015 Pyrogen and Endotoxins Testing guidance sets the CSF-contacting endotoxin limit at 2.15 EU/device — roughly an order of magnitude stricter than the 20 EU/device blood-contact limit. That tighter limit drives method selection (typically kinetic chromogenic LAL) and increases the importance of the inhibition/enhancement study.